Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes

The diabetogenic effect of statins has been well established by clinical trials, Mendelian randomisation studies and meta-analyses. According to large clinical trials, PCSK9 inhibitors (PCSK9i) have no deleter...

Source: Cardiovascular Diabetology - January 3, 2024 Category: Cardiology Authors: Ana M. Gonz ález-Lleó, Rosa M. Sánchez-Hernández, Núria Plana, Daiana Ibarretxe, Pere Rehues, Josep Ribalta, Dídac Llop, Ana M. Wägner, Lluís Masana and Mauro Boronat Tags: Research Source Type: research